Bradley Curtis Carthon

Author

Also Known As

Arash Rezazadeh Kalebasty, B C Carthon, B. C. Carthon, B. Carthon, B.C. Carthon, Bradley C Carthon, Bradley C. Carthon, Bradley Carthon, Bradley Curtis Carthon, Bradley C. Carthon

201

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Emory University Massachusetts General Hospital Winship Cancer Institute The Barbara Ann Karmanos Cancer Institute The University of Texas MD Anderson Cancer Center

About

Bradley Curtis Carthon is an author at Emory University specializing in urology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	20	851
2	Health Sciences	6	6	271
3	Public Health	1	1	20
4	Cell Biology	1	1	64
5	Cellular Physiology	1	1	64

Bradley Curtis Carthon

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial Bradley Curtis Carthon, Jedd D. Wolchok, Jianda Yuan, Clinical Cancer Research	2010	456
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial Ashesh B. Jani, Eduard Schreibmann, Subir Goyal, The Lancet Positron Emission TomographySurgical OncologyPostprostatectomy Salvage RadiotherapyMedical ImagingOncologic Imaging	2021	178
Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer Russell Z. Szmulewitz, Cody J. Peer, Abiola Ibraheem, Journal of Clinical Oncology UrologyPurpose Abiraterone AcetateMedicineMetronomic TherapyPharmacology	2018	177
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy Mehmet Asım Bilen, Dylan J. Martini, Yuan Liu, Cancer	2018	157
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy Mehmet Asım Bilen, Julie M. Shabto, Dylan J. Martini, BMC Cancer	2019	121
Epidermal growth factor receptor‐targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis Bradley Curtis Carthon, Chaan S. Ng, Curtis A. Pettaway, British Journal of Urology	2013	118
Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab Mehmet Asım Bilen, Giselle Dutcher, Yuan Liu, Clinical Genitourinary Cancer UrologyGenitourinary CancerMedicineImmune Checkpoint InhibitorCancer Treatment	2018	105
Genetic Replacement of Cyclin D1 Function in Mouse Development by Cyclin D2 Bradley Curtis Carthon, Carola A. Neumann, Manjusri Das, Molecular and Cellular Biology GeneticsMolecular GeneticsCytoskeletonCell CycleCellular Physiology	2005	64
Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation Jim Zhong, Jeffrey M. Switchenko, N. Jegadeesh, American Journal of Clinical Oncology	2018	62
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy Mehmet Asım Bilen, Dylan J. Martini, Yuan Liu, The Oncologist	2019	61

Page 1